Xiaohe Li

8.5k total citations · 1 hit paper
132 papers, 2.9k citations indexed

About

Xiaohe Li is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, Xiaohe Li has authored 132 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pulmonary and Respiratory Medicine, 29 papers in Epidemiology and 27 papers in Molecular Biology. Recurrent topics in Xiaohe Li's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (40 papers), Liver Disease Diagnosis and Treatment (17 papers) and Hepatitis C virus research (10 papers). Xiaohe Li is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (40 papers), Liver Disease Diagnosis and Treatment (17 papers) and Hepatitis C virus research (10 papers). Xiaohe Li collaborates with scholars based in China, United States and Singapore. Xiaohe Li's co-authors include Honggang Zhou, Cheng Yang, Lei Liu, Mindie H. Nguyen, Ramsey Cheung, Jie Li, Biyao Zou, Daniel Q. Huang, Zhaofang Jiang and Guobin Zhang and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and The Journal of Cell Biology.

In The Last Decade

Xiaohe Li

125 papers receiving 2.9k citations

Hit Papers

Epidemiology of COVID‐19: A systematic review and meta‐an... 2020 2026 2022 2024 2020 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaohe Li China 27 803 741 588 487 316 132 2.9k
Xin Zheng China 28 1.1k 1.3× 333 0.4× 663 1.1× 443 0.9× 220 0.7× 117 2.9k
Yuan Lin China 33 878 1.1× 703 0.9× 471 0.8× 937 1.9× 368 1.2× 216 4.2k
Jian Wu China 27 1.1k 1.4× 580 0.8× 239 0.4× 689 1.4× 463 1.5× 131 3.1k
Chao Wu China 30 1.0k 1.3× 516 0.7× 227 0.4× 1.0k 2.1× 190 0.6× 189 3.1k
Zuojiong Gong China 30 1.0k 1.3× 1.1k 1.5× 282 0.5× 1.1k 2.2× 485 1.5× 130 4.0k
Xiaoming Cheng China 21 748 0.9× 496 0.7× 148 0.3× 528 1.1× 403 1.3× 67 1.9k
Fang Li China 30 1.6k 2.0× 940 1.3× 347 0.6× 686 1.4× 377 1.2× 176 4.5k
Chen Dong China 22 1.1k 1.3× 602 0.8× 173 0.3× 676 1.4× 488 1.5× 76 2.6k
Qingling Zhang China 29 851 1.1× 1.3k 1.7× 540 0.9× 474 1.0× 350 1.1× 133 3.5k

Countries citing papers authored by Xiaohe Li

Since Specialization
Citations

This map shows the geographic impact of Xiaohe Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohe Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohe Li more than expected).

Fields of papers citing papers by Xiaohe Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohe Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohe Li. The network helps show where Xiaohe Li may publish in the future.

Co-authorship network of co-authors of Xiaohe Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohe Li. A scholar is included among the top collaborators of Xiaohe Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohe Li. Xiaohe Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jieying, et al.. (2025). Focused ultrasound-responsive artificial killer cells for enhanced closed-loop cancer immunotherapy. Materials Horizons. 12(19). 8134–8146. 1 indexed citations
2.
Guo, Xiaowei, Wenqi Li, Ma Wei, et al.. (2025). Daidzein alleviates skin fibrosis by suppressing TGF-β1 signaling pathway via targeting PKM2. Scientific Reports. 15(1). 8649–8649. 1 indexed citations
4.
Liang, Xieer, Qiaoqiao Chen, Hong Tang, et al.. (2025). Prevalence of Hepatitis D Virus Antibody Positivity in Chinese Patients with Chronic Hepatitis B Virus Infection. Journal of Clinical and Translational Hepatology. 0(0). 0–0.
5.
Li, Shimeng, Zhichao Liu, Xiaodan Jiao, et al.. (2024). Selpercatinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway. Biochemical Pharmacology. 225. 116282–116282. 2 indexed citations
6.
Xue, Tongtong, Qianyi Zhang, Tiantian Zhang, et al.. (2024). Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice. BMC Pulmonary Medicine. 24(1). 456–456. 4 indexed citations
7.
Wang, Xiaohan, Wenwei Ge, Enwei Sun, et al.. (2024). Multifunctional Sm3+ modified layered perovskite La2Ti2O7 single crystals: Enhanced piezoelectric performance and color-stable orange emission. Applied Physics Letters. 125(26). 2 indexed citations
8.
Yang, Miao, Yanhua Wang, Kai Huang, et al.. (2023). Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice. BMC Pulmonary Medicine. 23(1). 94–94. 7 indexed citations
9.
Xu, Zhixiang, Baisheng Li, Lebin Su, et al.. (2023). Development of a quadruple qRT-PCR assay for simultaneous identification of hypervirulent and carbapenem-resistant Klebsiella pneumoniae. Microbiology Spectrum. 12(1). e0071923–e0071923. 12 indexed citations
10.
Li, Wenqi, Jing Liu, Zhigang Liu, et al.. (2023). Zanubrutinib Ameliorates Cardiac Fibrosis and Inflammation Induced by Chronic Sympathetic Activation. Molecules. 28(16). 6035–6035. 6 indexed citations
11.
Li, Xiaohe, Xiaoyang Ma, Miao Yang, et al.. (2023). Duvelisib attenuates bleomycin‐induced pulmonary fibrosis via inhibiting the PI3K/Akt/mTOR signalling pathway. Journal of Cellular and Molecular Medicine. 27(3). 422–434. 20 indexed citations
12.
Yang, Jia, Jinlei Qi, Xiaohe Li, et al.. (2023). The burden of hepatitis C virus in the world, China, India, and the United States from 1990 to 2019. Frontiers in Public Health. 11. 1041201–1041201. 27 indexed citations
13.
Wang, Xiaoxiao, Zilong Wang, Ran Fei, et al.. (2023). Characteristic gene expression in the liver monocyte-macrophage-DC system is associated with the progression of fibrosis in NASH. Frontiers in Immunology. 14. 7 indexed citations
14.
Wang, Xiaohan, Fangfei Li, Wenwei Ge, et al.. (2023). Ultra-high Curie temperature transparent piezoelectric Bi doped Ca2Nb2O7 single crystals. Ceramics International. 50(2). 3151–3160. 7 indexed citations
15.
Liang, Jingjing, Jianwei Zhang, Zhichao Liu, et al.. (2023). Baricitinib Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice by Inhibiting TGF-β1 Signaling Pathway. Molecules. 28(5). 2195–2195. 22 indexed citations
16.
Gao, Shaoyan, Xiaohe Li, Ting Xiao, et al.. (2022). PKM2 promotes pulmonary fibrosis by stabilizing TGF-β1 receptor I and enhancing TGF-β1 signaling. Science Advances. 8(38). eabo0987–eabo0987. 60 indexed citations
17.
Yang, Bo, Ling Ma, Xiaohe Li, et al.. (2022). Isorhamnetin alleviates lipopolysaccharide-induced acute lung injury by inhibiting mTOR signaling pathway. Immunopharmacology and Immunotoxicology. 44(3). 387–399. 15 indexed citations
18.
Li, Hailong, Xiaohe Li, Shanshan Zhang, et al.. (2021). Diosmetin has therapeutic efficacy in colitis regulating gut microbiota, inflammation, and oxidative stress via the circ-Sirt1/Sirt1 axis. Acta Pharmacologica Sinica. 43(4). 919–932. 52 indexed citations
19.
Liu, Xue, Yingying Liu, Xiaohe Li, et al.. (2017). Follistatin like-1 (Fstl1) is required for the normal formation of lung airway and vascular smooth muscle at birth. PLoS ONE. 12(6). e0177899–e0177899. 17 indexed citations
20.
Li, Xiaohe, Chengyu Zhang, Huijuan Liu, et al.. (2017). Doxycycline attenuates paraquat-induced pulmonary fibrosis by downregulating the TGF-β signaling pathway. Journal of Thoracic Disease. 9(11). 4376–4386. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026